The combination drug valsartan/sacubitril (LCZ696) reduced pulse wave velocity and aortic systolic blood pressure in patients with stable heart failure with reduced ejection fraction

Authors
Kobalava Z. , Villevalde S. , Tyukhmenev E. , Lukina O.O. , Babaeva L. , Zharikova E.
Journal
European Journal of Heart Failure
Publisher
Elsevier Science Publishing Company, Inc.
Language
English
Pages
335-335
Status
Published
Volume
18
Year
2016
Cite
ГОСТ MLA RIS BibTex
Share

Other records